Tricida Inc. (NASDAQ: TCDA) stock fell -10.00% on Monday to $0.11 against a previous-day closing price of $0.12. With 28.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 15.23 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.1160 whereas the lowest price it dropped to was $0.0925. The 52-week range on TCDA shows that it touched its highest point at $13.85 and its lowest point at $0.12 during that stretch. Beta for the stock currently stands at 0.20.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TCDA was down-trending over the past week, with a drop of -27.27%, but this was down by -35.17% over a month. Three-month performance dropped to -99.05% while six-month performance fell -98.81%. The stock lost -98.80% in the past year, while it has lost -29.37% so far this year. A look at the trailing 12-month EPS for TCDA yields -2.37 with Next year EPS estimates of -1.16. For the next quarter, that number is -0.55. This implies an EPS growth rate of 34.90% for this year and 43.60% for next year.
Float and Shares Shorts:
At present, 58.02 million TCDA shares are outstanding with a float of 53.38 million shares on hand for trading. On Oct 13, 2022, short shares totaled 9.37 million, which was 16.84% higher than short shares on Sep 14, 2022. In addition to Dr. Gerrit Klaerner Ph.D. as the firm’s Founder, Pres, CEO & Exec. Director, Mr. Geoffrey M. Parker serves as its COO, CFO & Exec. VP.
Through their ownership of 100.45% of TCDA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 9.85% of TCDA, in contrast to 61.97% held by mutual funds. Shares owned by individuals account for 39.36%. As the largest shareholder in TCDA with 5.87% of the stake, Citadel Advisors LLC holds 3,407,597 shares worth 3,407,597. A second-largest stockholder of TCDA, BlackRock Fund Advisors, holds 2,748,098 shares, controlling over 4.74% of the firm’s shares. Commodore Capital LP is the third largest shareholder in TCDA, holding 1,975,403 shares or 3.40% stake. With a 2.48% stake in TCDA, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 1,439,241 shares are owned by the mutual fund manager. The Vanguard Wellington Fund – US Mom, which owns about 1.11% of TCDA stock, is the second-largest Mutual Fund holder. It holds 644,295 shares valued at 98577.0. iShares VII Plc – MSCI USA Small holds 0.91% of the stake in TCDA, owning 525,119 shares worth 80343.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TCDA since 3 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TCDA analysts setting a high price target of $20.00 and a low target of $20.00, the average target price over the next 12 months is $20.00. Based on these targets, TCDA could surge 18081.82% to reach the target high and rise by 18081.82% to reach the target low. Reaching the average price target will result in a growth of 18081.82% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. TCDA will report FY 2022 earnings on 03/27/2024. Analysts have provided yearly estimates in a range of -$1.88 being high and -$2.20 being low. For TCDA, this leads to a yearly average estimate of -$1.99. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Tricida Inc. surprised analysts by $0.10 when it reported -$0.44 EPS against a consensus estimate of -$0.54. The surprise factor in the prior quarter was $0.09. Based on analyst estimates, the high estimate for the next quarter is -$0.43 and the low estimate is -$0.66. The average estimate for the next quarter is thus -$0.51.
Summary of Insider Activity:
Insiders traded TCDA stock several times over the past three months with 0 Buys and 11 Sells. In these transactions, 0 shares were bought while 27,172,897 shares were sold. The number of buy transactions has increased to 46 while that of sell transactions has risen to 46 over the past year. The total number of shares bought during that period was 4,528,657 while 34,456,390 shares were sold.